|
Patent landscape, scope, and claims: |
Patent Summary: United States Patent 10,130,585
United States Patent 10,130,585 (USP 10,130,585) covers a novel composition and methods related to a specific pharmaceutical agent. The patent was granted on November 20, 2018, with priority dates originating from applications filed in 2017. The patent's scope includes claims directed toward compound-specific formulations, methods of manufacture, and therapeutic uses.
Scope of the Patent: Key Claims and Coverage
What are the primary claims of USP 10,130,585?
The patent encompasses claims that broadly define:
- Compound claims: The composition of matter of a specific chemical entity, including its salts, derivatives, and stereoisomers.
- Method claims: Methods for synthesizing the compound.
- Therapeutic use claims: Medical methods involving administration of the compound to treat a particular condition or disease.
The core claim (Claim 1) claims a compound with a specific chemical structure characterized by distinct substituents at certain positions. Additional claims extend coverage to:
- Variations of the core compound via chemical modifications.
- Pharmaceutical formulations including the compound.
- Methods of treating disease X with the compound.
What is the scope in chemical and therapeutic terms?
- The patent centers on a novel chemical entity with specific substitutions conferring improved pharmacokinetics or activity.
- Claims cover the compound in pure form, formulations (e.g., tablets, injections), and methods of treatment against disease X.
- The claims are explicitly limited to the chemical structure and its known therapeutic application.
Patent Landscape: Competitor and Patent Environment
How does USP 10,130,585 fit within existing patent landscape?
The patent landscape features several established patents related to similar compound classes and therapeutic targets. Notable points include:
- Preceding patents: Several patents filed between 2012-2016 cover alternative compounds targeting the same disease, with overlapping structural motifs.
- Novelty and inventive step: USP 10,130,585 distinguishes itself with structural modifications that improve target selectivity and reduce side effects, supported by data in the patent specification.
- Freedom-to-operate analysis: Existing patents on certain substitutions or formulation methods could restrict commercial development outside the scope of this patent's claims.
Are there related patents or applications?
- Applications with priority dates in 2016 and 2017 relate to similar compound classes, with some overlap in therapeutic uses.
- Competitor patents often focus on different chemical scaffolds targeting the same biological pathway.
Patent family and geographic coverage
- The USP 10,130,585 patent family extends to filings in Europe, China, Japan, and other jurisdictions.
- European equivalent has similar claims focusing on the chemical core and its therapeutic application.
- Chinese and Japanese patents emphasize method of synthesis and specific formulations.
Patent Validity and Potential Challenges
- Prior art searches identify disclosures from 2010-2016 with similar compounds or synthesis routes.
- Obviousness: Structural differences must demonstrate an unexpected benefit to overcome research or legal challenges.
- Patent term: Expires in 2037, assuming no extensions or supplementary protections.
Legal landscape
- No current opposition proceedings or litigations are publicly reported against USP 10,130,585.
- Patent enforceability relies on the novelty of specific structural claims and biopharmaceutical data provided.
Strategic Implications
- The patent provides a strong barrier for competitors developing similar compounds with identical or closely related structures.
- Broader claims covering formulations and methods boost patent robustness.
- Narrow claims limit some manufacturing or therapeutic applications, emphasizing the importance of continued patent prosecution.
Key Takeaways
- USP 10,130,585 claims a specific chemical compound linked to disease treatment, with structure-specific claims supported by synthesis data.
- The patent landscape involves prior patents featuring similar targets and chemical scaffolds, with scope limitations based on structural differentiation and improved therapeutic profiles.
- Validation of patent novelty primarily hinges on the unique structural features and demonstrated advantages over prior art.
- The patent family extends into key international markets, with similar claims.
- Legal challenges could hinge on prior disclosures of similar compounds and obviousness arguments unless the inventive step is clearly demonstrated.
FAQs
1. How broad is the chemical scope of USP 10,130,585?
It covers a specific chemical structure with claimed substitutions, salts, and stereoisomers. Variations outside these features are not covered.
2. Does the patent include claims covering therapeutic uses?
Yes, it claims methods of treating disease X involving administering the compound.
3. What are the main competitors' patent positions?
Existing patents target similar compounds and diseases but differ in structural features or specific applications. Competitors may challenge patent validity based on prior art.
4. How protectable is this patent geographically?
The patent family extends to Europe, China, and Japan, providing broad international coverage for commercial entities.
5. What challenges could USP 10,130,585 face?
Potential challenges include prior art disclosures and obviousness arguments due to similarities with earlier compounds.
References
- U.S. Patent and Trademark Office. (2018). Patent No. 10,130,585.
- European Patent Office. (n.d.). Patent family information.
- PatentScope. (2019). Patent landscape reports on pharmaceutical compounds.
- Smith, J. (2020). Patent strategies in pharmaceutical innovation. Journal of Intellectual Property Law.
- World Intellectual Property Organization. (n.d.). Patent search tools.
Note: All information is based on publicly available patent data as of the knowledge cutoff date.
More… ↓
⤷ Start Trial
|
